Skip to main content
Caplight Logo









VeCollal

VeCollal

Private
AntwerpHealthcare & Life Scienceshttps://vecollal.eu

Last Round

Early Funding

Dec 4, 2025

Company Overview

VeCollal operates in Healthcare & Life Sciences and is based in Antwerp. Its latest recorded funding round was an Early Funding round in December 2025.

VeCollal is a biotechnology company that develops plant-based, biomimetic collagen alternatives for use in the nutraceutical and cosmetic industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Sustainable Materials, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

VeCollal Comparables

Compare VeCollal with similar companies based on industry and business-model similarity.

VeCollal comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Jellatech
91%
Provenance Bio
87%
Geltor
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

VeCollal Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingDec 4, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

VeCollal Investors

Notable investors and investment history

VeCollal investors
InvestorRounds
Seventure PartnersEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors increased 517% MoM, reaching 6.8K.

  • Feb 1, 2026

    Monthly visitors grew 168% MoM, reaching 1.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

VeCollal Filings

Explore SEC and related filing metadata, where available.

VeCollal filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about VeCollal's valuation, stock price, and market status.

Is VeCollal a public or private company?

VeCollal is a private company.

What is the current stock price of VeCollal?

VeCollal is a private company, so its shares have no public market price. Caplight tracks VeCollal's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is VeCollal worth (valuation)?

Valuation information for VeCollal is not publicly available.

Can I buy VeCollal stock?

VeCollal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was VeCollal's last funding round?

VeCollal's most recent funding round was Early Funding on December 4, 2025.

Who are the main investors in VeCollal?

Key investors in VeCollal include Seventure Partners.

Will VeCollal IPO soon?

No public IPO plans have been announced for VeCollal.

How can I track VeCollal secondary market activity?

Caplight tracks bids, offers, and trades in VeCollal's shares on secondary markets.

Firmographic Details

HeadquartersAntwerp
Employee Range5
Year Founded2020
Last FundingDec 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?